title: Predicting the outcome of patients with higher-risk myelodysplastic syndrome treated with hypomethylating agents.
authors.affiliation: Service d' hématologie clinique, Hôpital Avicenne and Institut Gustave-Roussy, Paris, France.
authors.forename: Raphael
authors.initials: R
authors.lastname: Itzykson
authors.forename: Pierre
authors.initials: P
authors.lastname: Fenaux
mesh_terms: D001374:Azacitidine / Q000627:therapeutic use*; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000175:diagnosis*
chemical_list: D001374:Azacitidine